PAXUS ™ PM with Nanotechnology & Plant Cell Culture Technology, makes Paclitaxel more EFFECTIVE and SAFE to fight cancer cells

We are using a novel formulation of Paclitaxel encompassing Samyang’s Plant Cell Culture technology and proprietary Polymeric Micelle Technology

Using the state-of-art of Nanotechnology,
PAXUS ™ PM is in ideal nanoparticle size to improve the drug delivery system

Using Plant Cell Culture Technology,
PAXUS ™ PM is produced with :

  • High Concentration Cell Line
  • No Artificial Gene Modification
  • Completely Natural

What you should know about PAXUS™ PM

View Product Overview  


Clinical Studies For Healthcare Professionals

View Researches  

Frequently Asked Questions

Learn More about PAXUS™ PM

Learn More  

What is PAXUS™ PM?

Active pharmaceutical ingredient of PAXUS™ PM, is paclitaxel which belongs to the group of medicines called antineoplastics. This particular paclitaxel product contains no toxic solvents, unlike other conventional paclitaxel products. This may reduce some of the adverse effects such as allergic reactions that may be caused by these solvents other ingredients.

For Whom PAXUS™ PM is?

Currently PAXUS™ PM has been used as First-line treatment for Metastatic Breast Cancer (monotherapy), the first-line treatment for locally advanced, metastatic, recurrent Non-Small Cell Lung Cancer (NSCLC), and First-line treatment for Ovarian Cancer in combination with other chemotherapeutic agents.

What are the main benefits of PAXUS™ PM compared to conventional paclitaxel ?

  • Cremophor EL-free solubilizer, no severe hypersensitivity reaction
  • High dose, improved therapeutic effect with predictable safety profile
  • Hassle-free drug delivery, no special infusion set is required

Brand Name: PAXUS™ PM (South East Asia), GENEXOL® PM (Korea & other territories)